Pathophysiology News and Research

RSS

COVID-19 increases risk of developing Alzheimer's by 50-80% in older adults

In a recent study published in the Journal of Alzheimer’s Disease, researchers investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections could trigger the development of new-onset Alzheimer’s disease (AD)

18 Sep 2022

BU researcher urges the U.S. to create a National Long COVID Compensation Program

While the COVID-19 pandemic wanes, the U.S. continues to face a national health challenge – the effective and equitable care of individuals with Long COVID.

16 Sep 2022

UCLA professor wins NAM award for pioneering research and leadership in autism genetics

Dr. Daniel Geschwind, the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at UCLA, was awarded the National Academy of Medicine's (NAM) 2022 Rhoda and Bernard Sarnat International Prize in Mental Health in recognition of his pioneering research and leadership in autism genetics.

15 Sep 2022

Exercise hormone irisin blocks Parkinson's-associated α-synuclein aggregation and related neuronal toxicity

A new paper discusses the hope held out by recent results on a compound called irisin, a short protein secreted by skeletal muscle that produces some exercise-related effects on the brain.

15 Sep 2022

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

Researchers assessed the role of the gut microbiome in human health and disease.

8 Sep 2022

New agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.

8 Sep 2022

Scientists develop a model human gut microbiome

A team of US-based scientists has developed a novel bacterial community comprising 119 microbial species naturally found in the human body. The study is published in the journal Cell.

7 Sep 2022

How does SARS-CoV-2 affect the male genitourinary system?

In a recent paper published in the American Journal of Clinical and Experimental Urology, researchers reviewed existing data on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the male genitourinary (GU) tract.

7 Sep 2022

Persistent cardiac symptoms in individuals with mild initial COVID-19

In a recent study published in the journal Nature Medicine, researchers conducted serial cardiac assessments in individuals with mild initial coronavirus disease 2019 (COVID-19) who had no history of cardiac disease and significant comorbidities.

7 Sep 2022

Review explores the involvement of the endothelium as an important underpinning of long COVID’s pathophysiology

Researchers discussed possible mechanisms and potential treatment methods for endotheliopathy observed in patients with post-acute sequelae of SARS-CoV-2 infection.

6 Sep 2022

Neurological manifestations associated with monkeypox infection

A new study presents current information regarding the neurological presentations and complications of monkeypox infection.

5 Sep 2022

Early therapeutic interventions may be effective in treating Fragile X Syndrome

A new study suggests that therapeutic interventions to treat neurodevelopmental disorders may be more effective if done during the early stages of brain development.

1 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

α-synuclein is a neuronal protein involved in functions like vesicle trafficking and neurotransmitter release. It is typically found in abundance in a healthy brain.

30 Aug 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

Pathophysiology News and Research

COVID-19 increases risk of developing Alzheimer's by 50-80% in older adults

BU researcher urges the U.S. to create a National Long COVID Compensation Program

UCLA professor wins NAM award for pioneering research and leadership in autism genetics

Exercise hormone irisin blocks Parkinson's-associated α-synuclein aggregation and related neuronal toxicity

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

New agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease

Scientists develop a model human gut microbiome

How does SARS-CoV-2 affect the male genitourinary system?

Persistent cardiac symptoms in individuals with mild initial COVID-19

Review explores the involvement of the endothelium as an important underpinning of long COVID’s pathophysiology

Neurological manifestations associated with monkeypox infection

Early therapeutic interventions may be effective in treating Fragile X Syndrome

The currently available evidence on viral-induced parkinsonism

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

MRI shows brain microstructural changes after mild COVID-19

Researchers explore ocular lesions in monkeypox virus infections

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Latest News